ReportsnReports.com: Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) - Current Trends & Forecasts (2010 - 2015)
20-Aug-2011 | News-Press Release
Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceuticals market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1 percent from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90 percent- of the global radiopharmaceutical market.
Diagnostic applications of radiopharmaceuticals have around 90 percent of the market share. The market is growing due to the increasing incidences of cancer and cardiac diseases, requisition of better imaging techniques for diseases such as Alzheimer’s. Targeted alpha therapy is one of the most promising treatments for cancer, which is being researched upon by cancer institutes.
Browse All: Pharmaceuticals Market Research
Driven by the increasing incidence of cardiac and cancer diseases, early and accurate diagnosis, increasing awareness amongst the masses, and expanding application segment; the global radiopharmaceutical market reached around $3.2 billion in 2010. Radiopharmaceuticals are used for the diagnosis and treatment of various ailments such as cancer, cardiac, renal, and respiratory diseases among the others. PET machines enable radiologists in early detection of cancer, cardiac, and Alzheimer’s disease among the patients. This would increase the demand for PET machines among the healthcare centers and providers. Similarly, SPECT scanners have been on the forefront to bring about significant changes in the diagnostic imaging equipment landscape with opportunities in the market for neuroendocrine tumor imaging. For diagnostic applications of radiopharmaceuticals, radioisotopes such as FDG for PET and technetium for SPECT are most commonly used.
PET and SPECT scans provide dynamic images of the body’s interior, rather than just the bones, like X-ray and magnetic resonance imaging (MRI). PET scan lets the doctor identify glucose metabolism in different parts of the body in a patient. Cancer cells grow at a faster rate than the other cells. The machine detects the speed of glucose being used and indicates the presence of cancerous tumors. The cancerous cell breaks down glucose at a higher rate than the other cells and this increased activity can be seen in a scan. Thus, the use of PET and SPECT scans facilitates early and accurate diagnosis of diseases such as cancer. Increased usage of PET & SPECT scans in turn increases the demand for radiopharmaceuticals.
FDG is the major radiopharmaceutical used in PET (approximately 90 percent). PET procedures are preferred over SPECT as PET is more accurate, sensitive, and endowed with better spatial arrangement of the image. Besides, the main radiopharmaceutical used in SPECT; i.e. technetium (99m) has a limited supply, forcing people to look for alternatives. FDG can be produced at desired levels to meet all the imaging requirements. This situation is boosting the FDG market.
Most of the radiopharmaceuticals are used in hospitals; accounting for 92 percent. Majority of the radiopharmaceuticals are administered intravenously. The market for radiopharmaceuticals is restricted by their high cost and difficulties faced while transporting them.
Scope of the report
This research report categorizes the radiopharmaceuticals therapy and PET/SPECT imaging market on the basis of isotopes, routes of administration, applications, and geography; forecasting revenue, and analyzing trends in each of the following submarkets:
On the basis of isotopes:
Fludeoxyglucose (F18), Technetium (Tc99m), Gallium (Ga67), Sodium Iodide (I123), Iobenguane (I131), Rhenium (Re186), Samarium (Sm153),Thallium (Tl201), Yttrium (Y90), Erbium(Er169), and others
On the basis of routes of administration: Intravenous, peroral, inhalation, and others
On the basis of applications:
Diagnosis (PET and SPECT), indication for diagnosis, and therapy On the basis of geography: North America (U.S. and Canada), Europe, Asia-Pacific, Japan, and Rest of the World
Each section provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments. In addition, the report provides more than 16 company profiles covering all the sub-segments
You can read table of contents for Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) — Current Trends & Forecasts (2010 – 2015)
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
7557 Rambler road,
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
- Radiopharmaceuticals MarketPharmaceuticals Market Research ReportsMarket Research ReportsMarket ResearchIndustry AnalysisMarket ShareMarket Sizemarketing research
- ReportsnReports.com: Global Luxury Retailing: Market Size, Brand Strategies and Competitor Performance
- ReportsnReports.com: SiC Market
- ReportsnReports.com: Emerging Markets for Microfluidic Applications (EMMA 2011)
- ReportsnReports.com: WLCSP Market & Industrial Trends
- ReportsnReports.com: Outlet Center Retailing in Europe: Major Players, Strategies and New Opportunities
- ReportsnReports.com: Crop Protection Chemicals Market by Type (Herbicides, Fungicides, Insecticides, Bio-pesticides and Adjuvants)
- ReportsnReports.com: Global Enterprise VoWLAN Single-mode and DECT Phone Market
- ReportsnReports.com: Global Home Automation and Control Systems Market by Products and Technologies (2011-2016)
- ReportsnReports.com: Global Clinical Trials Market (2007 - 2010)
- ReportsnReports.com: Global Smartphone Security Market by Operating Systems, Ownership & Features (2011 2016)